NEW YORK (GenomeWeb) – Reaction Biology said today it has received a Small Business Innovation Research grant from the National Center for Advancing Translational Sciences to create a database of epigenetic drug interactions.

The Malvern, Pa.-based company said it will use the $288,000 grant to study the interactions of more than 1,400 drugs and drug-like compounds that have been approved by the US Food and Drug Administration.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.